Literature DB >> 7647309

Cyclin D1 as a cellular proto-oncogene.

S Bates1, G Peters.   

Abstract

Deregulated expression of cyclin D1 occurs in several types of human cancer. Since it often results from a specific chromosomal abnormality, this over-expression is likely to be significant in the development of the disease. Cyclin D1 is also implicated in virally induced tumors in mice and transgenic models based on ectopic expression if cyclin D1 recapitulate features of the naturally occurring tumors. By these criteria, as well as its effects in transfected rodent cells, cyclin D1 has the hallmarks of a cellular proto-oncogene. Although the normal role of cyclin D1 is not well understood, its oncogenic properties appear to involve functional interactions with cyclin-dependent kinases, the retinoblastoma gene product and the MTS1/p16 tumor suppressor gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7647309     DOI: 10.1006/scbi.1995.0010

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  27 in total

1.  Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis.

Authors:  K L Jordan-Sciutto; G Wang; M Murphy-Corb; C A Wiley
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 2.  RNA polymerase III transcription: its control by tumor suppressors and its deregulation by transforming agents.

Authors:  T R Brown; P H Scott; T Stein; A G Winter; R J White
Journal:  Gene Expr       Date:  2000

3.  The role of oncogenes in drug resistance.

Authors:  D Yu
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

4.  E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis.

Authors:  J Nip; D K Strom; B E Fee; G Zambetti; J L Cleveland; S W Hiebert
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

Review 5.  Signaling pathways that control cell proliferation.

Authors:  Robert J Duronio; Yue Xiong
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-03-01       Impact factor: 10.005

6.  Possible prognostic significance of p53, cyclin D1 and Ki-67 in the second primary malignancy of patients with double primary malignancies.

Authors:  Ming Dong; Hui Wei; Jun-Ming Hou; Shan Gao; De-Zhen Yang; Zhen-Hua Lin; Yong Jia; Xiao-Peng Ren; Mei-Hua Gao
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 7.  Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer.

Authors:  Junan Li; Ming Jye Poi; Ming-Daw Tsai
Journal:  Biochemistry       Date:  2011-06-06       Impact factor: 3.162

8.  Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6.

Authors:  Heike Laman; Juan M Funes; Hongtao Ye; Stephen Henderson; Laura Galinanes-Garcia; Eiji Hara; Phillip Knowles; Neil McDonald; Chris Boshoff
Journal:  EMBO J       Date:  2005-08-11       Impact factor: 11.598

9.  ETV4 Facilitates Cell-Cycle Progression in Pancreatic Cells through Transcriptional Regulation of Cyclin D1.

Authors:  Nikhil Tyagi; Sachin K Deshmukh; Sanjeev K Srivastava; Shafquat Azim; Aamir Ahmad; Ahmed Al-Ghadhban; Ajay P Singh; James E Carter; Bin Wang; Seema Singh
Journal:  Mol Cancer Res       Date:  2017-11-08       Impact factor: 5.852

Review 10.  Mechanism targeted discovery of antitumor marine natural products.

Authors:  Dale G Nagle; Yu-Dong Zhou; Flor D Mora; Kaleem A Mohammed; Yong-Pil Kim
Journal:  Curr Med Chem       Date:  2004-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.